Evommune Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Evommune Inc's ROI in the second quarter of 2026?
Evommune Inc recorded a cumulative net loss of $-123 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -55.97%.

Within the Healthcare sector Evommune Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	240.28 %	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	284	312	207	74	258
Return On Investment (TTM)	-55.97 %	-48.94 %	-71.97 %	-68.09 %	-68.31 %
EVMN's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	3.13 %	57.85 %	62.36 %	28.75 %	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-123	-104	-97	-57	-44

EVMN Company Profile >> Back to EVMN Roi Comparisons >> See Annual EVMN Return On Investment

Return On Investment EVMN's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Evommune Inc's II. Quarter Investments	$ 284 Millions	EVMN's Balance sheet
Evommune Inc's II. Quarter Income	$ -32 Millions	Quarterly EVMN's Income Statement
EVMN's Income by Division		See EVMN's Income by Division

EVMN Annual Return On Investment	(Dec 31 2025) 2025
Total Investments in Millions	207	0	0	0	0
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	-69	0	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-33.26 %	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EVMN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EVMN's Competitors
Subscribers only: Roi for Evommune Inc's Suppliers
Subscribers only: Return On Investment for EVMN's Customers

Other Ratios
EVMN's Roa	EVMN's Inventory Turnover Ratio	EVMN's Growth Rates	EVMN's Dividend Statistics
	EVMN's Profitability Ratios	EVMN's Asset Turnover Ratio	EVMN's Dividend Growth
EVMN's Roe	EVMN's Valuation Ratios	EVMN's Financial Strength Ratios	EVMN's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:43:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.